Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MULTIPLE SCLEROSIS Latest News

SEP 19, 2014 - Shape

A Must Read - Share

Multiple Sclerosis Can’t Slow Her Down!

If you were diagnosed with a debilitating disease, the first thing you’d do is...sign up for a triathlon? That’s what 40-year-old Aurora Colello did.At 19, Aurora moved to Hawaii and volunteered at Ironman Kona. She was awe-struck by the event and vowed to complete one someday.Fifteen years later as a wife and mother to four children under 7, she was ...

Tags: Multiple Sclerosis Can’t Slow Her Down!,  Multiple Sclerosis Latest News

SEP 18, 2014 - Family Practice News

A Must Read - Share

Trial probes mechanism of THC-CBD improvement of multiple sclerosis spasticity

BOSTON – A tetrahydrocannabinol and cannabidiol (THC-CBD) oromucosal spray significantly improved spasticity symptoms in a randomized, placebo-contr

Tags: Trial probes mechanism of THC-CBD improvement of multiple sclerosis spasticity,  Multiple Sclerosis Latest News

SEP 18, 2014 - MedPage Today

A Must Read - Share

Skull Size Tied to Disability Risk in MS

BOSTON (MedPage Today) -- Multiple sclerosis patients with larger intracranial volumes -- a measure of their lifetime maximal brain size -- scored better on cognition and physical function tests than those with smaller skull sizes.

Tags: Skull Size Tied to Disability Risk in MS,  Multiple Sclerosis Latest News

SEP 17, 2014 - MedPage Today

A Must Read - Share

Sativex Helps MS Spasticity in Objective Tests

BOSTON (MedPage Today) -- An objectively measured sign of spasticity in multiple sclerosis patients was relieved with Sativex, the oromucosal cannabinoid spray, in a small randomized trial reported here.

Tags: Sativex Helps MS Spasticity in Objective Tests,  Multiple Sclerosis Latest News

SEP 17, 2014 - Family Practice News

A Must Read - Share

VIDEO: Novel sphingosine 1-phosphate 1 receptor modulator has promising safety results

BOSTON – Treatment of relapsing-remitting multiple sclerosis patients with the investigational drug RPC1063, a selective, oral sphingosine 1-phosph

Tags: VIDEO: Novel sphingosine 1-phosphate 1 receptor modulator has promising safety results,  Multiple Sclerosis Latest News